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Intracellular iron homeostasis is critical for survival
and proliferation. Lipocalin 24p3 is an iron-trafficking
protein that binds iron through association with a
bacterial siderophore, such as enterobactin, or a
postulated mammalian siderophore. Here, we show
that the iron-binding moiety of the 24p3-associated
mammalian siderophore is 2,5-dihydroxybenzoic
acid (2,5-DHBA), which is similar to 2,3-DHBA, the
iron-binding component of enterobactin. We find
that the murine enzyme responsible for 2,5-DHBA
synthesis, BDH2, is the homolog of bacterial EntA,
which catalyzes 2,3-DHBA production during entero-
bactin biosynthesis. RNA interference-mediated
knockdown of BDH2 results in siderophore deple-
tion. Mammalian cells lacking the siderophore accu-
mulate abnormally high amounts of cytoplasmic
iron, resulting in elevated levels of reactive oxygen
species, whereas themitochondria are iron deficient.
Siderophore-depleted mammalian cells and zebra-
fish embryos fail to synthesize heme, an iron-depen-
dent mitochondrial process. Our results reveal
features of intracellular iron homeostasis that are
conserved from bacteria through humans.INTRODUCTION
The acquisition of iron by cells is critical for survival, growth, and
differentiation (Andrews, 2008). Cells require a constant source
of iron, which serves as a functional component of hemoproteins
and iron-sulfur (Fe-S) cluster-containing proteins. Almost all
mammalian cells and tissues are thought to acquire iron by
receptor-mediated endocytosis of iron-loaded transferrin. After
uptake, intracellular iron levels must be tightly regulated, as
excess free iron can catalyze the production of toxic reactive
oxygen species (ROS) (reviewed in Emerit et al., 2001).1006 Cell 141, 1006–1017, June 11, 2010 ª2010 Elsevier Inc.In addition to its cytoplasmic function, iron also has a critical
role in mitochondria, where heme and various Fe-S cluster-con-
taining proteins are synthesized (Rouault and Tong, 2005). Mito-
chondrial iron levels must be tightly regulated; an inadequate
supply of iron can impair the metabolic and respiratory activities
of the organelle, whereas excess mitochondrial iron promotes
the generation of ROS, which are produced as a side reaction
of mitochondrial electron transport (Foury and Cazzalini, 1997).
Iron is ultimately delivered to proteins or transporters bymetal-
lochaperones, such as the mitochondrial iron chaperone frataxin
(Bulteau et al., 2004) and the cytosolic iron chaperone PCBP1
(Shi et al., 2008). However, an unresolved question is the form
in which iron, which has low solubility in aqueous solution, is traf-
ficked from the transferrin-containing endosome to other cellular
sites, such as mitochondria. Although most cytoplasmic iron is
tightly bound to proteins, it is generally believed that a fraction
of cytoplasmic iron is complexed with a low molecular weight
carrier to form the ‘‘free’’ (also called labile or chelatable) iron
pool (Breuer et al., 2008). In support of this idea, several early
studies suggested that mammalian cells and tissues contain
low molecular weight siderophores that bind iron with high
affinity (Fernandez-Pol, 1978; Jones et al., 1980).
Recently, new evidence for the existence of a mammalian
siderophore has emerged from studies of the lipocalin 24p3
(also known as lipocalin-2 [LCN2]). Lipocalins are a family of
secreted proteins that can bind small molecular weight ligands
and have diverse molecular recognition properties and functions
(Akerstrom et al., 2000). 24p3 has been found to be involved in
multiple biological processes including apoptosis (Devireddy
et al., 2005), innate immunity (Flo et al., 2004), and renal develop-
ment (Yang et al., 2002).
Several groups have shown that 24p3 can bind iron and deliver
it to or remove it from cells (Devireddy et al., 2005; Goetz et al.,
2002; Yang et al., 2002). The iron status of 24p3 is the critical
determinant of its activity. Iron-containing 24p3 (holo-24p3)
binds to a cell surface receptor called 24p3R, is internalized,
and releases its bound iron, thereby increasing intracellular
iron concentration (Devireddy et al., 2005). By contrast, iron-
lacking 24p3 (apo-24p3) binds to 24p3R, is internalized, chelates
iron, and transfers it to the extracellular medium, thereby reduc-
ing intracellular iron concentration.
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Figure 1. 2,5-DHBA Is the Iron-Binding
Moiety of the 24p3-Associated Mammalian
Siderophore
(A) Immunoblot analysis showing 24p3 in the CM
of FL5.12 cells expressing either vector or Ec-24p3
in the presence or absence of ponasterone A.
(B) Iron binding assay. 24p3 was immunoprecipi-
tated from the CM of cells described in (A) and
analyzed for the presence of 55Fe. CPM, counts
per minute. Error bars indicate the standard devi-
ation (SD).
(C) Top: GC-MS analysis on the TMS-derivatized,
small-molecule flow-through fraction eluted from
immunopurified 24p3. Bottom: matching spec-
trum from the NIST database.
(D) GC-MS analysis on the eluted sample from im-
munopurified 24p3 and a set of DHBA standards.
(E) Chemical structures of 2,3-DHBA and 2,5-
DHBA.
(F) Tryptophan fluorescence quenching assay.
2,3-DHBA (left) or 2,5-DHBA (right) was added to
apo-24p3 at increasing concentrations, and tryp-
tophan fluorescence was monitored. Error bars
indicate the SD.
(G) Iron binding assay. Purified apo-24p3 was
incubated with 55FeCl3 and increasing concentra-
tions of 2,3-DHBA, 2,5-DHBA, iron-free entero-
bactin, or desferrichrome, and radioactivity was
measured in the 24p3 immunoprecipitate. Error
bars indicate the SD.
See also Figure S1.24p3 does not have an intrinsic ability to interact with iron,
but rather binds iron through an associated, small molecular
weight, iron-chelating compound (Devireddy et al., 2005; Goetz
et al., 2002; Yang et al., 2002). Significantly, the classic bacterial
siderophore, enterobactin, can bind 24p3 and function as the
iron-chelating moiety (Yang et al., 2002). Interestingly, apo-24p3
produced in enterobactin-deficient bacteria acquires iron-
binding ability after delivery to, and internalization in, mammalian
cells (Devireddy et al., 2005). These results indicate that mam-
malian cells contain a siderophore, which may have structural
and functional similarities to bacterial enterobactin.
Here, we characterize the iron-binding moiety of the 24p3-
associated mammalian siderophore and identify one of the
cellular enzymes involved in its synthesis. This information has
enabled us to deplete the siderophore from mammalian cells
and zebrafish embryos and study the role of the siderophore in
intracellular iron homeostasis.Cell 141, 1006–101RESULTS
2,5-DHBA Is the Iron-Binding
Moiety of the 24p3-Associated
Mammalian Siderophore
We have previously shown that FL5.12
cells, a murine interleukin-3 (IL-3)-depen-
dent pro-B lymphocytic cell line, harbor
an intracellular cofactor that enables
24p3 to bind iron (Devireddy et al.,
2005). To gain insight into the composi-tion of this cofactor, we derived an FL5.12 cell line stably
expressing an ecdysone-inducible, epitope-tagged derivative
of 24p3 (FL5.12/Ec-24p3 cells). Figure 1A shows that treatment
of FL5.12/Ec-24p3 cells with the ecdysone analog ponasterone
A resulted in the accumulation of 24p3 in the conditioned
medium (CM). To test whether the induced 24p3 was able to
bind iron, we added radiolabeled iron (55FeCl3) to the CM, immu-
noprecipitated 24p3, and assessed 24p3 iron binding by
measuring radioactivity in the 24p3 immunoprecipitate. Fig-
ure 1B shows that 24p3 present in the CM from ponasterone
A-treated FL5.12/Ec-24p3 cells bound to 55Fe, indicating, as
expected, that the 24p3 was siderophore associated.
To identify the 24p3-associated siderophore, we immunopre-
cipitated 24p3 from the CM of ponasterone A-treated FL5.12/
Ec-24p3 cells, eluted the putative 24p3-siderophore complex
with acetic acid, and then separated protein from small mole-
cules by size-exclusion chromatography. The small molecule7, June 11, 2010 ª2010 Elsevier Inc. 1007
flow-through fraction was derivatized with trimethylsilate (TMS)
and subjected to gas chromatography-mass spectrometry
(GC-MS). As shown in Figure 1C, a single prominent GC peak
was detected at 355 m/z (mass-to-charge ratio), and a search
of the National Institute of Standards and Technology (NIST)
database of known MS spectra yielded a match to tri-TMS-
2,5-dihydroxybenzoic acid (tri-TMS-2,5-DHBA), which was
confirmed using a set of DHBA standards (Figure 1D). GC-MS
analysis under milder conditions [N,O-Bis(trimethylsilyl)trifluor-
oacetamide (BSTFA)-pyridine] did not yield a peak for tri-TMS-
2,5-DHBA, whereas free 2,5-DHBA was fully derivatized (data
not shown), indicating that the 24p3-associated 2,5-DHBA is
a component of a larger molecule. Notably, 2,5-DHBA could
also be detected and quantified by TMS derivatization and
GC-MS analysis of cytoplasmic extracts from FL5.12 cells cul-
tured in the presence of IL-3 (Figure S1A available online), which
lack 24p3 (Devireddy et al., 2001).
2,5-DHBA is related to 2,3-DHBA (Figure 1E), the iron-binding
moiety of bacterial enterobactin (reviewed in Raymond et al.,
2003). We performed several experiments to determine whether,
like 2,3-DHBA, 2,5-DHBA could also chelate iron and bind
24p3. The iron-binding pocket of 24p3 has a single tryptophan
residue, and the occupation of this site by enterobactin or 2,3-
DHBA quenches its intrinsic fluorescence (Goetz et al., 2002).
Figure 1F (left panel) shows, consistent with previous results,
that addition of 2,3-DHBA quenched the intrinsic fluorescence
emitted by tryptophan. Addition of 2,5-DHBA also quenched
tryptophan fluorescence (Figure 1F, right panel), indicating
that 2,5-DHBA bound to 24p3. 2,5-DHBA and 2,3-DHBA
bound 24p3 with roughly comparable affinities of 12 and 8 nM,
respectively, as calculated by nonlinear regression analysis. As
expected, desferrichrome, a structurally unrelated siderophore
that does not bind to 24p3 (Flo et al., 2004; Goetz et al., 2002),
had no effect on tryptophan fluorescence (Figure S1B).
We next assessed the ability of 2,5-DHBA to confer iron
binding to 24p3. Purified apo-24p3 was incubated with 55FeCl3
and increasing concentrations of 2,5-DHBA or, as positive
controls, 2,3-DHBA or enterobactin, and, after immunoprecipita-
tion of 24p3, radioactivity wasmeasured in the 24p3 immunopre-
cipitate. Figure 1G shows that addition of 2,3-DHBA, enterobac-
tin, or 2,5-DHBA to apo-24p3 conferred the ability to bind iron,
whereas desferrichrome did not. The greater level of iron binding
observed with enterobactin compared to DHBA is most likely
due to the higher affinity of enterobactin for 24p3 (Goetz et al.,
2002). Order-of-addition experiments confirmed that 2,5-DHBA
could stably bind to 24p3 in the absence of iron (Figure S1C).
Identification of a Murine Homolog of Bacterial EntA
that Mediates 2,5-DHBA Synthesis
In bacteria, synthesis of 2,3-DHBA from its precursor, 2,3-dihy-
dro-2,3-dihydroxybenzoic acid (2,3-diDHBA), is catalyzed by
the EntA protein (Liu et al., 1989). The finding that themammalian
siderophore had structural similarities to enterobactin prompted
us to perform database searches for proteins homologous to
bacterial EntA. As shown in Figure 2A, these searches revealed
putative human, mouse, zebrafish, and yeast homologs of EntA.
The human homolog was identified as a short-chain dehydroge-
nase/reductase family member originally called DHRS6 and now1008 Cell 141, 1006–1017, June 11, 2010 ª2010 Elsevier Inc.referred to as BDH2 (Guo et al., 2006). RT-PCR analysis indi-
cates that themurineBdh2 gene waswidely expressed inmouse
tissues (Figure S2A).
TodeterminewhetherBDH2was in fact involved in synthesis of
24p3-associated 2,5-DHBA, we derived two unrelated short
hairpin RNAs (shRNAs) directed against murine Bdh2 (Bdh2-1
and Bdh2-2). The RT-PCR and immunoblot results of Figure 2B
show that both shRNAs knocked down Bdh2 expression.
Bdh2-1 was more efficient than Bdh2-2 at knocking down
Bdh2 expression, which is relevant to results of some of the func-
tional experiments presented below. We then repeated the
GC-MSanalysis of Figure 1C inBDH2 knockdown (KD) cells. Fig-
ure 2C shows that in contrast to parental FL5.12 cells, in BDH2
KD cells there was no detectable 24p3-associated 2,5-DHBA.
Finally, we tested whether BDH2 was a functional homolog of
bacterial EntA by asking whether it could catalyze an equivalent
enzymatic reaction. The NAD+-dependent oxidation of 2,3-
diDHBA to 2,3-DHBA can be monitored by ultraviolet (UV)
fluorescence (Liu et al., 1989). Figure 2D (left panel) shows, as
expected, that E. coli EntA efficiently catalyzed the production
of 2,3-DHBA from 2,3-diDHBA, whereas this reaction was not
catalyzed by an EntA derivative containing a point mutation
(Tyr144 to Phe) within the predicted active site (Filling et al.,
2002). Significantly, 2,3-DHBA production was also catalyzed
by recombinant BDH2 but not by a mutant BDH2 derivative
(Tyr147 to Phe). As expected, in these same reactions wild-
type EntA and BDH2 proteins, but not their mutant derivatives,
catalyzed the conversion of NAD to NADH (Figure 2D, right
panel). Collectively, these results indicate BDH2 is a homolog
of bacterial EntA.
BDH2 Is Required for 24p3-Mediated Iron
Transport and Apoptosis
The finding that after BDH2 knockdown there was no detectable
24p3-associated 2,5-DHBA suggested that 24p3 would be
unable to bind iron in BDH2 KD cells. To test this prediction, we
analyzed 24p3 iron-binding activity in cells expressing a Bdh2
shRNA. Figure 3A shows that 24p3 present in the CM from
IL-3-deprived FL5.12 cells or ponasterone A-treated FL5.12/
Ec-24p3 cells bound to 55Fe, whereas 24p3 iron-binding activity
was markedly decreased in BDH2-depleted cells despite near-
equivalent amounts of 24p3 in the CM.
We next performed a series of experiments to analyze the
ability of 24p3 to mediate iron transport in BDH2-depleted cells.
After receptor-mediated internalization, apo-24p3 chelates
intracellular iron and exits the cell via the recycling endosome,
thereby transferring iron to the extracellular medium. The
resultant decrease in intracellular iron concentration induces
apoptosis (Devireddy et al., 2005). We predicted that in the
absence of a functional siderophore, apo-24p3 would be unable
to deplete intracellular iron and therefore fail to induce apoptosis.
As a first test of this prediction, we analyzed the ability of apo-
24p3 to transfer iron to the extracellular medium in BDH2 KD
cells. FL5.12 cells were loaded with radiolabeled iron by preincu-
bation with 55FeCl3 followed by reculturing in fresh medium
lacking 55Fe. 55Fe-loaded cells were treated with apo-24p3 or,
as a control, the membrane-permeable iron chelator desferriox-
amine (DFO), and the accumulation of 55Fe in the medium was
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S. cerevisiae ----MGKVILVTGVSRGIGKSIVDVLFSLDKDTVVYGVARSEAPLKKLKE 46
E. coli       -MDFSGKNVWVTGAGKGIGY--ATALAFVEAGAKVTG--FDQAFTQEQYP 45
M. musculus   YRG-----IQTRVLDVTKKRQIDQ-FASEIERIDVLFNVAGFVH-HGTIL 91
H. sapiens    YPG-----IQTRVLDVTKKKQIDQ-FANEVERLDVLFNVAGFVH-HGTVL 91
D. rerio      IPG-----IKTKVVDVTKKDQVDA-LAKDFDHVDVLFNIAGFVH-HGSIL 91
S. cerevisiae KYGDRFFYVVGDITEDSVLKQLVNAAVKGHGKIDSLVANAGVLEPVQNVN 96
E. coli       FAT-----EVMDVADAAQVAQVCQRLLAETERLDALVNAAGILR-MGATD 89
M. musculus   DCEEKDWDFSMNLNVRSMFLMIKAFLPKMLAQKSGNIINMSSVASSIKGV 141
H. sapiens    DCEEKDWDFSMNLNVRSMYLMIKAFLPKMLAQKSGNIINMSSVASSVKGV 141
D. rerio      DCEESDWDFTMNVNVRSMYLMIKAFLPKMLARKSGNIINMASVASSIKGV 141
S. cerevisiae EIDVNAWKKLYDINFFSIVSLVGIALPELKKTN-GNVVFVSSDACNMYFS 145
E. coli       QLSKEDWQQTFAVNVGGAFNLFQQTMNQFRRQRGGAIVTVASDAAHTPRI 139
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Figure 2. Identification of a Murine Homolog of Bacterial EntA that Mediates 2,5-DHBA Synthesis
(A) Multiple sequence alignment of EntA/BDH2 homologs. Identical residues between all five proteins are indicated in yellow, conserved residues in green, and
semiconserved residues in blue.
(B) RT-PCR (left) and immunoblot (right) analysis monitoring murine Bdh2 expression in FL5.12 cells treated with one of two unrelated shRNAs targeting Bdh2 or
a control nonsilencing (NS), enhanced green fluorescent protein (EGFP), or luciferase (Luc) shRNA.
(C) GC-MS analysis of the eluted 24p3 sample prepared from parental FL5.12 cells or FL5.12 cells expressing a Bdh2 shRNA.
(D)Wild-type andmutant bacterial EntA andmouse BDH2 proteins were analyzed for their ability to convert 2,3-diDHBA to 2,3-DHBA (left) or NAD to NADH (right).
Error bars indicate the SD. Mutant EntA/BDH2 proteins were expressed at comparable levels to the wild-type proteins (Figure S2C).
See also Figure S2.determined by liquid scintillation counting. Figure 3B shows that
addition of apo-24p3 or DFO to control nonsilencing shRNA-
treated cells led to the time-dependent accumulation of 55Fe in
the medium. By contrast, in BDH2 KD cells, DFO but not apo-
24p3 was able to transfer 55Fe to the extracellular medium.
We next analyzed the ability of 24p3 to induce apoptosis. We
have previously shown that in FL5.12 cells, IL-3 deprivation
induces 24p3 expression, resulting in apoptosis (Devireddy
et al., 2001). Figure 3C shows that in BDH2 KD FL5.12 cells,
the level of apoptosis resulting from IL-3 deprivation was mark-
edly reduced compared to cells treated with a nonsilencing
shRNA. Remarkably, addition of 2,5-DHBA restored the ability
of BDH2 KD FL5.12 cells to induce apoptosis after IL-3 depriva-
tion. Notably, in FL5.12 cells cultured in the presence of IL-3, and
which therefore do not express 24p3, addition of 2,5-DHBA did
not promote apoptosis. Collectively, these results indicate that
BDH2 is required for synthesis of the 24p3-associated mamma-lian siderophore and thus for 24p3-mediated iron binding and
trafficking activities.
BDH2 Is Required to Maintain Normal Cytoplasmic
Iron Levels
Next, we performed a series of experiments to determine the role
of the siderophore in intracellular iron homeostasis. First, we
used a colorimetric assay to measure cytoplasmic iron concen-
tration in cells containing or lacking the siderophore. The results
of Figure 4A show that total cytoplasmic iron levels were mark-
edly elevated in BDH2 KD cells. Second, we measured free
iron concentration using calcein, a fluorescent cell-permeable
dye whose emission is quenched by iron binding (Kakhlon and
Cabantchik, 2002). Figure 4B shows that BDH2 KD cells con-
tained substantially higher free iron levels, as evidenced by a
decrease in fluorescence intensity. Similar results were obtained
in murine mIMCD kidney cells (Figures S3A–S3C).Cell 141, 1006–1017, June 11, 2010 ª2010 Elsevier Inc. 1009
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Figure 3. BDH2 Is Required for 24p3-Medi-
ated Iron Transport and Apoptosis
(A) Iron-binding assay. Left: FL5.12 cells were
treated in the presence or absence of IL-3, and
with a Bdh2 or control shRNA, and the iron-binding
ability of 24p3 in the CM was monitored as
described in Figure 1B. Inset: immunoblot analysis
monitoring 24p3 levels in the CM and tubulin levels
in the whole-cell extract (WCE). Right: FL5.12/
Ec-24p3 cells were treated in the presence or
absence of ponasterone A. Error bars indicate
the SD.
(B) Iron exocytosis assay. 55FeCl3-loaded FL5.12
cells were either untreated (control) or treated
with apo-24p3 or DFO, and the presence of 55Fe
in the medium was quantified. Error bars indicate
the SD.
(C) Apoptosis assay. FL5.12 cells cultured in the
presence or absence of IL-3, with or without 2,5-
DHBA, and expressing a NS or Bdh2 shRNA
were analyzed for apoptosis by annexin V-FITC
staining. Error bars indicate the SD.Intracellular iron levels were also assessed by immunoblotting
for two iron-regulated proteins, ferritin-L and transferrin receptor
1 (TFR1). In BDH2 KD cells, ferritin-L levels were substantially
elevated (Figure 4C and Figure S3D), whereas TFR1 levels
were decreased (Figure 4D), both of which are indicative of
increased intracellular iron concentration.
We also analyzed the iron-regulatory proteins IRP1 and IRP2.
Upon elevated iron concentration, IRP2 undergoes rapid protea-
somal degradation (Iwai et al., 1995). InBDH2KDcells IRP2 levels
were decreased, indicative of increased iron concentration
(Figure 4D). IRP1 contains an Fe-S cluster that, upon elevated
iron concentration, undergoes a conformational switch, convert-
ing the RNA-binding protein to a cytosolic aconitase (Rouault
et al., 1991). We found that BDH2 KD cells had increased cyto-
solic aconitase activity, as expected if cytoplasmic iron levels
are elevated (Figure 4E, and see also Figure S4). Thus, based
upon multiple, independent lines of evidence, cells lacking a
functional siderophore accumulate abnormally high levels of
cytoplasmic iron.1010 Cell 141, 1006–1017, June 11, 2010 ª2010 Elsevier Inc.The Siderophore Protects Cells
from Oxidative Stress
Free iron can generate ROS, prompting
us to measure ROS levels in sidero-
phore-depleted cells. In these experi-
ments, we imposed an oxidative stress
by addition of hydrogen peroxide. In the
first set of experiments, the accumulation
of ROS was measured by preloading
cells with the nonfluorescent probe
20-70 carboxy-dichlorodihydrofluorescein-
diacetate (CDDHCF-DA), which is rapidly
converted to the highly fluorescent
compound 20,70-carboxy-dichlorofluor-
escein-diacetate (CDCF-DA) by ROS.
The results, assayed by either flow cy-
tometry (Figure 5A) or fluorometry (Fig-ure 5B and Figure S3E), show that in BDH2 KD cells there was
higher ROS production as evidenced by increased CDCF-DA
fluorescence. Significantly, basal ROS levels in the absence of
hydrogen peroxide were also substantially higher in BDH2 KD
cells (Figure 5A).
Increased ROS can lead to apoptosis (reviewed in Simon et al.,
2000). Therefore, we predicted that siderophore depletion would
result in increased apoptosis after oxidative stress. To test this
idea, we treated cells with hydrogen peroxide and measured
apoptosis by annexin V-FITC staining. The results of Figure 5C
show that siderophore-depleted cells were markedly more sen-
sitive to oxidative stress-induced apoptosis, consistent with their
elevated cytoplasmic iron levels.
BDH2 Is Required for Mitochondrial Iron Homeostasis
We next performed a series of experiments to assess mitochon-
drial iron levels in siderophore-depleted cells. Unexpectedly,
total mitochondrial iron levels were significantly reduced in
BDH2 KD cells (Figure 6A and Figure S3F). To confirm this result,
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Figure 4. BDH2 Is Required to Maintain Normal Cytoplasmic Iron
Levels
FL5.12 cells expressing a Bdh2 or control shRNA were analyzed for total
cytoplasmic iron levels by colorimetric analysis (A), for free cytoplasmic iron
concentration by fluorescence calcein assay (B), for ferritin-L (C) and TFR1
and IRP2 (D) levels by immunoblot analysis, and for cytosolic aconitase activity
(E). Error bars indicate the SD. See also Figures S3A–S3D and S4.we analyzed incorporation of radioactive iron into mitochondria.
In brief, iron-deprived cells were labeled with 55FeCl3, mitochon-
dria were isolated (Figure S5), and the amount of incorporated
55Fe quantified. Figure 6B shows that mitochondrial radio-
active iron incorporation was significantly reduced after BDH2
knockdown.
We next asked whether mitochondrial free iron was also
altered in siderophore-depleted cells. The fluorescent mitochon-
drial iron indicator rhodamine B-[(1,10-phenanthrolin-5-yl)ami-
nocarbonyl]benzyl ester (RPA) contains a rhodamine moiety for
mitochondrial targeting and a 1,10-phenanthroline moiety for
iron chelation; iron binding quenches the fluorescence of RPA
(Rauen et al., 2007). After RPA addition, fluorescence was signif-
icantly higher in BDH2 KD cells than in control cells (Figure 6C
and Figure S3G), indicative of reduced mitochondrial iron levels.
A control experiment using a structurally similar compound,
rhodamine B-[(phenanthren-9-yl)aminocarbonyl]benzyl (RPAC),
which contains the same fluorophore and linker as RPA but lacks
iron-chelating properties and thus has fluorescence that is not
responsive to iron (Rauen et al., 2007), confirmed that the results
of Figure 6C are explained by differences in mitochondrial iron
levels and not by an inability of RPA to enter into the mitochon-
dria of BDH2 KD cells (Figure 6D, and see also Figure S3H).The lower concentration of mitochondrial free iron in BDH2 KD
cells should result in reduced levels of mitochondrial ROS. To
test this prediction, we measured mitochondrial ROS by incu-
bating cells with the redox-sensitive probe dihydrorhodamine
(DHR 123), which is converted by oxidation to the fluorescent
compound rhodamine 123. After DHR 123 loading and hydrogen
peroxide addition, fluorescence intensity in BDH2 KD cells was
significantly reduced, indicative of decreased mitochondrial
ROS (Figure 6E and Figure S3I).
As a final confirmation of altered mitochondrial iron levels,
we measured the activity of several iron-dependent mitochon-
drial enzymes. Figure 6F shows that the activities of the Fe-S
cluster-containing enzymes, mitochondrial aconitase and succi-
nate dehydrogenase, were substantially reduced in BDH2 KD
cells (see also Figure S3J). By contrast, citrate synthase, which
does not contain an Fe-S cluster and whose function is not
iron dependent, was comparably active in control and BDH2
KD cells.
The results described above raised the possibility that iron is
imported into mitochondria as an iron-siderophore complex.
To provide additional support for this conclusion, we performed
a series of in vitromitochondrial iron import experiments. Proteo-
lytically treated cytosolic extracts from control or BDH2 KD cells
were added to purified mitochondria, and iron import was deter-
mined by monitoring mitochondrial incorporation of 55FeCl3. The
results of Figure 6G (left panel) show that all control cytosolic
extracts supported substantial levels of mitochondrial iron
import. Significantly, mitochondrial iron import was markedly
reduced in reaction mixtures containing cytosolic extracts from
BDH2 KD cells. In a second experiment, we found that addition
of 2,5-DHBA, 2,3-DHBA and, to a lesser extent, enterobactin
enabled purified mitochondria to import radioactive iron (Fig-
ure 6G, right panel). By contrast, DFO failed to support mito-
chondrial iron import.
Requirement of Vertebrate EntA Homologs for Heme
Synthesis
Synthesis of heme occurs in the mitochondria and insufficient
mitochondrial iron is known to decrease heme synthesis, result-
ing in lower hemoglobin levels (reviewed in Napier et al., 2005).
To determine the role of BDH2 in synthesis of heme and hemo-
globin, we performed an initial series of experiments in mouse
erythroleukemia (MEL) cells. Untreated MEL cells or MEL cells
expressing a control or BDH2 shRNA were differentiated into
erythroid cells by addition of dimethyl sulfoxide and assayed
for the production of heme and hemoglobin. We found that
BDH2 knockdown resulted in decreased levels of both heme
(Figure 7A, and see Figure S4) and hemoglobin (Figure 7B).
The RT-PCR results of Figure 7C show that expression of
a- and b-globin was normal in BDH2 KD cells and is thus not
responsible for the decreased hemoglobin levels.
To confirm and extend these cell culture results, we analyzed
the role of the siderophore in zebrafish embryos. As stated
above, we found that zebrafish also contained an EntA homolog
(see Figure 2A). Whole-mount in situ hybridization analysis
revealed that bdh2 messenger RNA (mRNA) was widely distrib-
uted throughout the zebrafish embryo (Figure S6A). To ablate
Bdh2 function in zebrafish embryos, we designed an antisenseCell 141, 1006–1017, June 11, 2010 ª2010 Elsevier Inc. 1011
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Figure 5. The Siderophore Protects Cells from Oxidative Stress
(A) FL5.12 cells expressing a NS or Bdh2 shRNA and treated in the presence or absence of hydrogen peroxide (H2O2) were analyzed for ROS by monitoring
CDCF-DA fluorescence with flow cytometry. Error bars indicate the SD.
(B) FL5.12 cells expressing a control or Bdh2 shRNA were analyzed for ROS by monitoring CDCF-DA fluorescence with fluorometry. Error bars indicate the SD.
(C) FL5.12 cells expressing a control or Bdh2 shRNA were treated in the presence or absence of H2O2 and apoptosis was measured by annexin V-FITC staining.
Error bars indicate the SD.
See also Figure S3E.morpholino oligonucleotide (MO) to induce an aberrant splicing
event, which was confirmed by RT-PCR analysis (Figure 7D).
The bdh2 MO was injected into wild-type one-cell-stage fertil-
ized embryos in parallel with a randomized control MO. Figure 7E
shows that bdh2 MO-injected embryos developed normally
and were morphologically indistinguishable from control MO-
injected embryos. Notably, however, Bdh2-depleted embryos
had hypochromic blood (i.e., lacking red color), suggesting an
absence of hemoglobinized erythrocytes. Identical results were
obtained with a second, unrelated bdh2 MO (Figure S6B).
To determine the basis for the hypochromia, we analyzed
hemoglobin content by whole-embryo staining with o-dianisi-
dine, a heme-specific stain (Iuchi and Yamamoto, 1983). Control
MO-injected embryos displayed intense o-dianisidine staining at
the duct of Cuvier and the heart, indicative of normal hemoglobi-
nized blood flow over the yolk sac, whereas Bdh2-depleted
embryos exhibited a marked reduction in o-dianisidine staining
(Figure 7F and Figure S6B). Reduced o-dianisidine staining
was also evident in blood cells isolated from Bdh2-depleted
embryos (Figure 7G). Injection of a bdh2mRNA bearing a muta-
tion that prevented hybridization with the bdh2 MO rescued
the normal pattern of o-dianisidine staining in Bdh2-depleted
embryos (Figure 7H). Notably, in Bdh2-depleted embryos the
globin genes hbae1 and hbae3 were expressed normally
(Figure 7I), indicating that the decreased hemoglobin levels are
not due to reduced globin gene expression.1012 Cell 141, 1006–1017, June 11, 2010 ª2010 Elsevier Inc.DISCUSSION
In this study, we have confirmed the existence of a mammalian
siderophore and provided insight into its structure, biosynthesis,
and function. We have identified a mammalian homolog to EntA,
a bacterial protein that has a critical role in synthesis of the
bacterial siderophore enterobactin. RNA interference-mediated
knockdown of BDH2 depletes cells of the siderophore and
results in profound dysregulation of cytoplasmic and mitochon-
drial iron levels (summarized in Figure S7). The majority of our
experiments were performed in hematopoietic FL5.12 cells,
but BDH2 is broadly expressed (Figure S2A), and we have
obtained similar results in other mammalian cell types (Figures
7A–7C and Figure S3). Finally, we have also identified putative
zebrafish and yeast homologs (see Figure 2A) with functional
similarities to mammalian BDH2 (Figures 7D–7I and Figure S4,
respectively). Collectively, our results reveal features of intracel-
lular iron homeostasis that are conserved from bacteria through
humans.
Although we have identified the iron-binding moiety of the
mammalian siderophore, the composition and structure of the
intact siderophore remain to be determined. Notably, in addition
to EntA, we have identified putative mammalian homologs of
EntE and EntF (Figure S2B), two proteins required for the final
stage of enterobactin synthesis. These results suggest that there
are likely to be additional similarities between the biosynthetic
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Figure 6. BDH2 Is Required for Mitochon-
drial Iron Homeostasis
(A–F) FL5.12 cells expressing a Bdh2 or control
shRNA were analyzed for mitochondrial iron levels
by colorimetric analysis (A), for mitochondrial iron
uptake (B), for RPA (C) and RPAC (D) fluorescence
by fluorometry, for DHR 123 oxidation in the pres-
ence or absence of H2O2 by flow cytometry (E),
and for activities of mitochondrial aconitase,
succinate dehydrogenase, and citrate synthase
(F). Error bars indicate the SD.
(G) In vitro mitochondrial iron import. Left: proteo-
lytically treated cytosolic extracts from control or
Bdh2 shRNA-treated FL5.12 cells were added to
purified mitochondria, and iron import was deter-
mined by monitoring of mitochondrial incorpora-
tion of 55FeCl3. Right: purified mitochondria were
treated with 2,3-DHBA, 2,5-DHBA, enterobactin,
or DFO, and iron import was monitored. Error
bars indicate the SD.
See also Figures S3F–S3J and S5.pathways of the mammalian siderophore and bacterial entero-
bactin.
Role of the Mammalian Siderophore in Cytoplasmic
Iron Homeostasis
Although the vast majority of intracellular iron is safely bound to
proteins, a small portion of intracellular iron (0.2%–3%) is bound
to low-molecular weight ligands and forms a transit pool for intra-
cellular trafficking and synthesis of iron-containing proteins.
A number of putative iron-binding ligands have been identified,Cell 141, 1006–101including peptides, proteins, and nucleo-
tides (Breuer et al., 2008). However, the
function of these putative iron-binding
ligands in iron trafficking and homeo-
stasis has not been established.
We have presented several lines of
evidence that demonstrate that the iron-
siderophore complex is a critical func-
tional component of the intracellular
free iron pool. First, the ability of intracel-
lularly delivered apo-24p3 to substantially
deplete cells of iron indicates that much
of the cytoplasmic free iron is bound
to the siderophore (Devireddy et al.,
2005). Second, depletion of the sidero-
phore profoundly perturbs intracellular
iron homeostasis, resulting in markedly
increased cytoplasmic iron levels. The
increased cytoplasmic iron levels in side-
rophore-depleted cells is due, at least in
part, to decreased transport of iron from
the cytoplasm to the mitochondria (see
below).
We have found that siderophore-
depleted cells contain higher levels of
ROS and are substantially more sensitiveto oxidative stress. Previous studies have shown that chelated
iron is much less reactive than free iron in generating ROS
(Blat et al., 2008; Lukinova et al., 2009). Thus, we propose that
a major function of the siderophore is to protect cells from oxida-
tive stress while providing a source of free iron.
Role of the Siderophore in Mitochondrial
Iron Homeostasis
Several lines of evidence indicate that the siderophore we have
identified here plays an important role in mitochondrial iron7, June 11, 2010 ª2010 Elsevier Inc. 1013
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Figure 7. Requirement of Vertebrate EntA Homologs for Heme Synthesis
(A) MEL cells expressing a NS or Bdh2 shRNAwere differentiated. After labeling with 55Fe, cells were lysed, and heme was extracted and analyzed for 55Fe incor-
poration. Error bars indicate the SD.
(B) MEL cells were differentiated as described in (A), and after cell lysis, hemoglobin levels were determined by benzidine reaction. Hemoglobin content was
expressed relative to that in untreated MEL cells cultured in the absence of dimethyl sulfoxide. Error bars indicate the SD.
(C) MEL cells were differentiated as described in (A), and a- and b-globinmRNA levels weremonitored by RT-PCR. The levels ofBdh2 andGapdhweremonitored
as controls.
(D) RT-PCR analysis. The bdh2MOwas injected into one-cell-stage embryos, and 24 hr later, RNA was extracted and analyzed by RT-PCR. Treatment with the
bdh2 MO resulted in retention of the entire intron (upper band) as well as activation of a cryptic splice site that resulted in partial intron retention (lower band).
(E) Phenotypic analysis of control MO- and bdh2MO-injected embryos at 72 hr postfertilization (hpf). Bdh2-depleted embryos lack hemoglobinized erythrocytes,
as evidenced by the absence of red color (arrow).
(F) Whole-mount o-dianisidine staining of control MO and bdh2MO-injected embryos at 72 hpf. Shown are lateral (top) and ventral (bottom) views of the anterior
region of embryos. Control MO-injected embryos show positive o-dianisidine staining at the duct of Cuvier (DC) and the heart (H), which is markedly reduced in
bdh2 MO-injected embryos. Right: quantification of the percent embryos with normal o-dianisidine staining.
(G) Blood cells were isolated from control or bdh2 MO-injected embryos and analyzed for hemoglobinization by o-dianisidine staining.
(H) Whole-mount o-dianisidine staining of embryos (72 hpf) injected with a control MO or bdh2MO, or bdh2MO-treated embryos coinjected with a bdh2mRNA.
(I) RT-PCR (left) and in situ hybridization analysis (right) for hbae1 and hbae3 expression in control and bdh2 MO-injected embryos.
See also Figures S4E and S6.
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import. First, we have found that despite markedly elevated
cytoplasmic iron levels, the mitochondria of siderophore-
depleted cells are iron deficient. Second, our in vitro mitochon-
drial import experiments provide evidence that iron is imported
into mitochondria as an iron-siderophore complex (see Fig-
ure 6G). Previous studies have identified two proteins involved
in mitochondrial iron import, mitoferrin 1 (MFRN1) and mitoferrin
2 (MFRN2), which are homologous members of the mitochon-
drial solute carrier family (Paradkar et al., 2009; Shaw et al.,
2006). What, then, is the relationship between the siderophore-
and MFRN-mediated iron import pathways? One possibility is
that there are two independent mitochondrial import pathways,
one involving MFRNs and a second involving the siderophore.
Alternatively, a parsimonious explanation for these collective
results is that the iron-siderophore complex, rather than free
iron, is the form in which iron is transported by MFRNs.EXPERIMENTAL PROCEDURES
Cell Lines
FL5.12/Ec-24p3 cells were generated as previously described (Devireddy
et al., 2001). MEL cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and differ-
entiated by incubation in 1.5% dimethyl sulfoxide.
24p3-Iron Binding Assays
CM from ponasterone A-treated FL5.12/Ec-24p3 cells or IL-3-deprived FL5.12
cells was incubated with 5 mCi 55FeCl3 (Perkin-Elmer) overnight at 4
C. 24p3
was immunoprecipitated from the CM of FL5.12/Ec-24p3 cells with an anti-HA
antibody (Santa Cruz Biotechnology) or from the CM of IL-3-deprived FL5.12
cells with a rabbit polyclonal anti-24p3 antibody raised against full-length
recombinant 24p3-derived from E. coli strain BL21. The immunoprecipitate
was analyzed for the presence of 55Fe by liquid scintillation counting.
For the in vitro iron binding assays of Figure 1G, purified apo-24p3 (Goetz
et al., 2002) was incubated with 500 nM 55FeCl3 and increasing concentrations
of 2,3-DHBA, 2,5-DHBA, iron-free enterobactin (EMC Microcollections), or
desferrichrome (EMC Microcollections). After immunoprecipitation of 24p3,
radioactivity was measured in the 24p3 immunoprecipitate.
Gas Chromatography-Mass Spectrometry
The immunopurified 24p3-siderophore complex was incubated with 1%
acetic acid for 2 hr at room temperature and passed through a Centricon
YM-10 column (Millipore). The small molecule flow-through fraction was deriv-
atized with BSTFA-pyridine (N,O-bis[Trimethylsilyl]trifluoroacetamide; Pierce
Biotechnology), 1:1 at 80C for 1 hr and subjected to GC-MS. The NIST library
search was performed against 191,436 MS spectra (http://www.nist.gov/srd/
nist1a.htm). DHBA standards were obtained from Sigma Chemical Company.
GC-MS analysis was also performed under milder conditions (BSTFA-pyri-
dine, 1:1 at 40C for 15 min).
Tryptophan Fluorescence Quenching Assay
In brief, 120 nM apo-24p3 was incubated with increasing amounts of 2,3- or
2,5-DHBA, and the fluorescence intensity was determined at 280 nm (excita-
tion)/340 nm (emission) as previously described (Goetz et al., 2002).
EntA Homolog Identification
The E. coli EntA protein (NP_415128) was used to perform BLAST searches
against nonredundant protein sequence databases to identify homologs in
Mus musculus (NP_081484.1; also known as BDH2/DHRS6), Homo sapiens
(NP_064524.3; BDH2/DHRS6), Danio rerio (NP_001017809.1; zgc:110323),
and Saccharomyces cerevisiae (NP_012301.1; YIR035C). The amino acid
sequences were aligned using ClustalW2 sequence analysis software.RNA Interference
Nonsilencing (RS1707), luciferase (RHS1705), and EGFP (RHS1706) shRNAs
were purchased from Open Biosystems, and Bdh2 shRNAs were synthesized
(Table S1). Naive FL5.12 or FL5.12/Ec-24p3 cells were transduced with retro-
viruses expressing shRNAs and selected for puromycin resistance (2 mg/ml).
Knockdown efficiency was assessed by RT-PCR (see Table S1 for primer
sequences) or by immunoblot analysis with a rabbit polyclonal antibody raised
against recombinant E. coli EntA protein or a monoclonal anti-a-tubulin anti-
body (Sigma).
2,3-diDHBA Oxidation Assay
Site-directed mutagenesis to create the Y144F/Y147F mutant was performed
with a kit from Stratagene. Wild-type and mutant EntA proteins were purified
as previously described (Sundlov et al., 2006) and assayed for enzymatic
activity as previously described (Liu et al., 1989). Conversion of 2,3-diDHBA
to 2,3-DHBA was monitored at 306 nm (excitation)/437 nm (emission), and
the conversion of NAD to NADH was measured at 340 nm.
Iron Exocytosis Assays
FL5.12 cells expressing a nonsilencing or Bdh2 shRNA were deprived of iron
by culturing in serum-free minimal essential medium (MEM) supplemented
with IL-3 for 12 hr and then incubated with 100 mCi 55FeCl3 in serum-containing
MEM supplemented with IL-3 for 24 hr. Labeled cells were washed, placed in
fresh growth medium and treated with 10 mg GST or apo-24p3 or 100 mMDFO
(Calbiochem), and the accumulation of 55Fe in the medium was determined by
liquid scintillation counting.
Assessment of Intracellular Iron Levels
For determination of total cytoplasmic iron, mitochondrial-depleted cyto-
plasmic extracts were analyzed with Iron Color Reagent (Sigma). Iron con-
centrations in the samples were calculated from a standard curve plotted
from iron standards (Sigma). Free iron was measured with the iron-sensitive
probes Calcein Green (CALG; Molecular Probes) or Blue (B-AM; Molecular
Probes), and RPA or RPAC (Axxora), for cytosolic and mitochondrial compart-
ments, respectively, according to the manufacturer’s instructions. For
immunoblot analysis, blots were probed with antibodies against Ferritin-L
(Santa Cruz Biotechnology), TFR-1 (Zymed), or IRP2 (Novus Biologicals).
Blots were stripped and reprobed with an a-tubulin antibody (Santa Cruz
Biotechnology).
Total mitochondrial iron was determined by colorimetric assay as described
above. For measurement of mitochondrial incorporation of radioactive iron,
cells were labeled with 55FeCl3 as described above, mitochondria from labeled
cells were isolated (see the Extended Experimental Procedures), and the
amount of incorporated 55Fe was determined by liquid scintillation. To assess
mitochondrial free iron, cells were treated with 1 mM RPA or RPAC, and fluo-
rescence was measured at 544 nm (excitation)/590 nm (emission).
Measurement of ROS
The redox-mediated conversion of nonfluorescent CDDHCF-DA (25 mM) to the
fluorescent CDCF-DAwasmeasured either by flow cytometry orwith a fluores-
cence plate reader (488 nm [excitation]/517 nm [emission]). Mitochondrial ROS
formation was determined by analysis of oxidation of DHR 123 (50 mM) to
rhodamine 123 by fluorometry (485 nm [excitation]/535 nm [emission]) or
flow cytometry. Cytosolic and mitochondrial ROS were also determined after
treatment with 50 mM H2O2 for 24 hr. Apoptosis was measured by annexin
V-FITC staining 24 hr after treatment with 100 mM H2O2.
Enzymatic Activity Assays
Cytosolic aconitase activity was measured as previously described (Gardner
et al., 1994); one unit was defined as the amount of enzyme necessary to
produce 1 mM NADPH per minute (e340 = 3.13 mM1 cm1; extinction coef-
ficient adjusted for the path length of the solution in the well). Mitochondrial
aconitase was determined as previously described (Campanella et al., 2009)
with an extinction coefficient of 1.8 mM1 cm1. Citrate synthase activity
was assayed as previously described (Powell and Jackson, 2003) with an
extinction coefficient of 6.8 mM1 cm1. Succinate dehydrogenase wasCell 141, 1006–1017, June 11, 2010 ª2010 Elsevier Inc. 1015
assayed as previously described (Campanella et al., 2009) with an extinction
coefficient of 9.65 mM1 cm1.
In Vitro Mitochondrial Iron Import Assays
Cytosolic extracts (50 mg) from control or BDH2 KD FL5.12 cells were treated
with 1 unit of carboxypeptidase immobilized onto agarose beads (Thermo
Scientific) overnight at 4C, and the beads removed by centrifugation. The
treated extracts were then incubated with 100 mM 55FeCl3 for 1 hr at 37
C.
Extracts were then added to purified mitochondria (0.02 mg) isolated from
naive cells and incubated for 1 hr at 37C, and the amount of 55Fe in lysedmito-
chondria was determined by liquid scintillation. For control experiments, 1 mM
2,3-DHBA, 2,5-DHBA, DFO, or iron-free enterobactin was incubated with 1 mM
55FeCl3 (or 3 mM for enterobactin) overnight at 4
C, followed by addition of
mitochondria (0.01 mg), incubation for 1 hr at 37C, and determination of
55Fe in lysed mitochondria.
Heme and Hemoglobin Quantification
Heme measurements were performed as described previously (Shaw et al.,
2006). In brief, differentiated MELs were washed with 13 phosphate-buffered
saline (PBS), placed in MEM supplemented with 0.5% FBS for 2 hr at 37C,
and then placed in DMEM supplemented with 5% dialyzed FBS and 55Fe-
Transferrin with 1.2 mM v-aminolevulinic acid for 8 hr at 37C. Cells were
then washed with 13 PBS and lysed in RIPA lysis buffer. Hemoproteins
were denatured by addition of 0.1 N HCl, and heme was extracted by addition
of an equal amount of cyclohexanone. The CPM in the organic phase was then
determined by liquid scintillation counting. For hemoglobin quantification,
differentiated MELs were washed with 13 PBS and lysed with 1.5% octyl
glucoside for 30 min on ice. The lysates were clarified by centrifugation at
13,000 rpm for 10 min at 4C. For hemoglobin determination, a volume corre-
sponding to 50 mg of protein was added to 100 ml freshly prepared benzidine
(0.5 mg/ml in 10% acetic acid) and 10 ml 30% H2O2. After 10 min, optical
density was determined at 604 nm in a plate reader (Perkin Elmer). RT-PCR
analysis was performed with the primers listed in Table S1.
Zebrafish Experiments
Whole-mount in situ hybridization was performed as previously described
(Hart et al., 2007). Riboprobes were prepared from full-length zebrafish
complementary DNAs (cDNAs) cloned into the pGEM-T TA cloning vector
(Promega) (see Table S1 for primer sequences). Staining for o-dianisidine
was performed as previously described (Detrich et al., 1995).
MOs (Table S1) were injected into one- to two-cell-stage wild-type embryos
at a range of concentrations, and their effect on morphology was assessed
up to 72 hr after injection. For rescue experiments, full-length human BDH2
cDNA was amplified from p11-DHRS6 (provided by Upo Opperman), fused
in frame at the C terminus with myc, and inserted into pCS2+ (provided by
David Turner). Capped sense mRNA was synthesized with the mMESSAGE
mMACHINE kit (Ambion) and injected immediately after MO injections into
the same embryos. For RT-PCR analysis, total RNA was prepared with Trizol
reagent (Invitrogen), and RT-PCR was performed with the primers listed in
Table S1.
Circulating blood cells were isolated from zebrafish by tail amputation as
previously described (Brownlie et al., 1998). Cells were cytospun onto glass
slides and fixed for 5 min in 12% glacial acetic acid containing 0.4% benzidine
(Sigma). H2O2 was added to a final concentration of 0.3%, and cells were incu-
bated at room temperature for 10–15 min and photographed immediately.
Statistical Analysis
Results were analyzed with either ANOVA or Student’s t test, and for all graphs
presented, p < 0.05.SUPPLEMENTAL INFORMATION
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